SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer

Table 1

The correlation between SPARCL1 protein expression and clinicopathological features.

		Total	High (positive) expression	Low (negative) expression	value
Hu HG 2012(COH) (10)	Distant metastasis				0.911
	Yes	42	12	30
	No	180	53	127
Hu HG 2012(ZJU) (10)	Distant metastasis				0.01
	Yes	40	10	30
	No	372	172	200
Wang XY 2014 (11)	Distant metastasis				0.039
	Yes	28	5	23
	No	76	30	46
Hu HG 2012(COH) (10)	Lymph node metastasis				0.322
	Yes	55	19	36
	No	167	46	121
Hu HG 2012(ZJU) (10)	Lymph node metastasis				0.049
	Yes	183	71	112
	No	229	111	118
Wang XY 2014 (11)	Lymph node metastasis				0.022
	Yes	69	18	51
	No	35	17	18
Han W 2018 (12)	Duke stage				0.421
	A + B	44	19	25
	C + D	35	12	23
Zhang H 2011 (13)	Duke stage				0.032
	A + B	87	75	12
	C + D	77	56	21
Wang XY 2014 (11)	Duke stage				0.022
	A + B	35	17	18
	C + D	69	18	51
Hu HG 2012(COH) (10)	Differentiation				0.852
	High	19	6	13
	Low	193	57	136
Hu HG 2012(ZJU) (10)	Differentiation				0.001
	High	159	86	73
	Low	253	96	157
Wang XY 2014 (11)	Differentiation				0.536
	High	12	5	7
	Low	91	30	61
Han W 2018 (12)	Differentiation				0.238
	High	13	7	6
	Low	66	24	42
Zhang H 2011 (13)	Differentiation				0.012
	High	114	97	17
	Low	50	34	16